Anatara Lifesciences Ltd Sustainability Reports
Anatara Lifesciences Ltd focuses on developing and commercializing innovative, evidence-based oral solutions for gastrointestinal diseases in humans and animals. Its research mainly targets complex gastrointestinal tract conditions and non-antibiotic treatments like dietary supplements.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
FIGI: BBG0077TH9J5
6 reports from 2015 to 2023